Test Price
4,800 AED✅ Home Collection Available
Endocrine Cancer Gene Panel in UAE – NGS Hereditary Profiling
Executive Summary & Core Metrics
- Accuracy Guarantee: >99.9% diagnostic sensitivity via next-generation sequencing (NGS) in an ISO 9001:2015 accredited laboratory.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM – 11 PM).
- Clinical Guidance: Post-test telephonic result interpretation by a DHA-licensed Consultant Medical Geneticist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731. Accepted by all major UAE networks.
Test Overview & Methodology
The Endocrine Cancer Gene Panel uses next-generation sequencing (NGS) to analyse ≥30 genes associated with hereditary endocrine tumour syndromes, including multiple endocrine neoplasia (MEN1, MEN2), familial medullary thyroid carcinoma, and familial paraganglioma. Performed on a peripheral blood sample, results are available within 4–6 weeks, enabling early surveillance and personalised risk management.
| Feature | Endocrine Cancer Gene Panel (NGS) | Single‑Gene Alternative |
|---|---|---|
| Precision & Method | NGS – full panel covering ≥30 genes | Sanger sequencing of one gene (e.g., RET) |
| Diagnostic Sensitivity | >99.9% for nucleotide variants in targeted regions | High for one gene, misses mutations in other endocrine genes |
| Turnaround Time | 4–6 weeks (comprehensive multi‑disciplinary review) | 3–4 weeks |
| Clinical Actionability | Covers MEN1, MEN2, familial medullary thyroid cancer, paraganglioma – actionable surveillance protocols | Limited to one syndrome; additional tests required |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist, I view comprehensive panel testing as essential for individuals with suspected hereditary endocrine cancer syndromes. A negative result does not fully exclude risk, and any positive finding must be interpreted within the context of family history and clinical presentation. Genetic counselling before and after testing is strongly recommended to ensure informed decision‑making.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
⚠ Important Safety Information
- Do not discontinue prescribed medication without consulting your treating physician. Genetic testing does not replace ongoing clinical management.
- If you experience acute endocrine symptoms (severe headache, palpitations, uncontrolled hypertension, sudden vision loss) – seek emergency care immediately; do not wait for genetic results.
Exclusion Criteria & Critical Precautions
- Haemolysed or clotted specimens will be rejected.
- Not validated for individuals who have undergone allogeneic bone marrow transplant.
- Pre‑ and post‑test genetic counselling is strongly recommended.
- Test requires a valid prescription from a DHA/MOHAP licensed physician (exceptions may apply for specific cases – please consult our team).
Patient FAQ & Clinical Guidance
1. Is the Endocrine Cancer Gene Panel suitable for children?
Yes, when clinically indicated, the panel can be ordered for minors under strict parental consent, in compliance with UAE Federal Law No. 2 of 2019 on health data and after pre‑test genetic counselling. Parental or legal guardian presence is mandatory, and the collection procedure is adapted for paediatric comfort.
2. How should I prepare for the blood draw?
No fasting is required. Please inform the phlebotomist of all medications and supplements, as some may interfere with DNA extraction. Our team will provide a medication disclosure form before the draw.
3. What happens if a variant of uncertain significance (VUS) is found?
A VUS result means the genetic change cannot be clearly linked to disease at this time. It requires periodic re‑evaluation as scientific knowledge evolves. Our clinical team will provide a follow‑up plan and recommend family testing if indicated.
4. How do I book a home collection?
Contact us via WhatsApp at +971 54 548 8731 to schedule a VIP mobile phlebotomy appointment between 8 AM and 11 PM daily. Our temperature‑controlled courier ensures sample integrity.
UAE Regulatory & Data Privacy Adherence
- Data Protection: This service complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genomic data is encrypted and stored within UAE sovereign data centres.
- Medical Liability: Clinical testing and consent procedures adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Quality Assurance: Laboratory accredited under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). All processing follows CLSI and CAP standards.
- Insurance & Support: For billing or insurance verification, contact us 24/7 via WhatsApp +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | Endocrine Cancer Gene Panel (NGS) |
| Price (AED) | 4,800 AED |
| Turnaround Time | 4–6 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube) |
| Methodology Used | Next‑Generation Sequencing (NGS) – targeted gene panel |
| ICD-10-CM Code | Z15.04 (Genetic susceptibility to malignant neoplasm of endocrine glands) |
| LOINC Code | 55233-5 (Hereditary cancer panel – Blood) |
| DHA Facility License & Address | DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians